March 15, 2026 Update: The federal court overseeing GLP-1 drug lawsuits continues organizing pretrial proceedings for claims alleging Ozempic, Wegovy and Mounjaro caused stomach paralysis and other severe gastrointestinal injuries
These drugs, which stimulate insulin release and reduce appetite, offer promising therapeutic options for managing blood sugar levels and supporting weight loss in individuals with these conditions
Sponsors evaluating a GLP-1 CDMO increasingly look for partners that combine: Together, these capabilities enable reliable production of long, modified peptides at commercial scale
For underwriters, the key is context: GLP-1s should appear alongside those respiratory machines referenced above
Quercetin enhances adriamycin cytotoxicity through induction of apoptosis and regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase/c-Jun N-terminal kinase signaling in multidrug-resistant leukemia K562 cells